Literature DB >> 169248

Thyrotropin receptors in thyroid plasma membranes. Characteristics of thyrotropin binding and solubilization of thyrotropin receptor activity by tryptic digestion.

R L Tate, H I Schwartz, J M Holmes, L D Kohn.   

Abstract

Biologically active bovine 125I-thyrotropin preparations have been prepared, characterized, and used to evaluate the optimal conditions for thyrotropin binding to bovine thyroid plasma membranes in vitro. Binding of 125I-TSH has a pH optimum around 6.0 and is sensitive to the choice and concentration of buffer. Binding is inhibited by salts, especially those containing magnesium and calcium ions; magnesium concentrations optimal for adenylate cyclase assays (2 to 5 mM) result in 85 to 98% inhibition of binding. Binding is temperature sensitive. At 37 degrees binding has its highest initial level; however, instability of the membrane at this temperature causes a rapid loss of binding activity. Binding at 0 degrees is optimal in 30 min and at the same level as initial binding at 37 degrees; since there is no decrease in binding activity, it has been chosen as the optimal temperature. Thyrotropin, luteinizing hormone, the beta subunit of thyrotropin, and the alpha subunit of thyrotropin have relative binding affinities for the thyrotropin receptors of 100, 10, 2, and less than 0.5, respectively. In all of these characteristics, 125I-thyrotropin at 1.5 x 10(-5) M concentrations has the same properties of binding to bovine plasma membranes as do [3H]thyrotropin preparations which have been previously characterized (Amir, S.M., Carraway, T.F., Jr., Kohn, L.D., and Winand, R.V. (1973) J. Biol. Chem. 248, 4092-4100) and used to study binding at 5 x 10(-6) M concentrations. 125I-TSH binding as a function of hormone concentration results in curved Scatchard plots; however, Hill plots of these same binding data are linear and have a slope of 0.65. Taken together, these data suggest that the heterogeneity in thyrotropin binding constants which is evident in the Scatchard plot reflects a negatively cooperative relationship among the thyrotropin receptor sites, i.e. decreased hormonal affinity as hormone concentrations increase. Adenylate cyclase studies yield kinetic plots which also exhibit negative cooperativity; corrections for thyrotropin bound under the adverse binding conditions of the adenylate cyclase assays suggest that Km values for thyrotropin in this enzymatic assay are compatible with binding constants measured by the 125I-thyrotropin preparations. Tryptic digestion destroys binding activity on the thyroid plasma membrane but releases specific thyrotropin receptor activity into the supernatant phase. Chromatography on Sephadex G-100 indicates that this solubilized receptor fragment has a molecular weight between 15,000 and 30,000.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 169248

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Radio-receptor assay of TSH: its use to detect thyroid-stimulating immunoglobulins.

Authors:  G Fenzi; E Macchia; L Bartalena; F Mazzanti; L Baschieri; L J DeGroot
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

2.  Effect of various solubilizers on angiotensinII receptors in bovine adrenocortical plasma membranes.

Authors:  G Forget; S Heisler
Journal:  Experientia       Date:  1979-01-15

3.  Cholera toxin interactions with thyrotropin receptors on thyroid plasma membranes.

Authors:  B R Mullin; S M Aloj; P H Fishman; G Lee; L D Kohn; R O Brady
Journal:  Proc Natl Acad Sci U S A       Date:  1976-05       Impact factor: 11.205

4.  Contribution of negative cooperativity to the thyrotropin-receptor interaction in normal human thyroid: kinetic evaluation.

Authors:  C H Powell-Jones; C G Thomas; S N Nayfeh
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

Review 5.  The thyrotrophin receptor.

Authors:  S W Manley; A Knight; D D Adams
Journal:  Springer Semin Immunopathol       Date:  1982

6.  Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease.

Authors:  W A Valente; P Vitti; Z Yavin; E Yavin; C M Rotella; E F Grollman; R S Toccafondi; L D Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

7.  Monoclonal antibodies to the thyrotropin receptor: the identification of blocking and stimulating antibodies.

Authors:  W A Valente; Z Yavin; E Yavin; E F Grollman; M Schneider; C M Rotella; R Zonefrati; R S Toccafondi; L D Kohn
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

8.  Effects of thyrotropin on the thyroid cell membrane: hyperpolarization induced by hormone-receptor interaction.

Authors:  E F Grollman; G Lee; F S Ambesi-Impiombato; M F Meldolesi; S M Aloj; H G Coon; H R Kaback; L D Kohn
Journal:  Proc Natl Acad Sci U S A       Date:  1977-06       Impact factor: 11.205

9.  Effects of manganese ions on thyroid function in rat.

Authors:  A M Buthieau; N Autissier
Journal:  Arch Toxicol       Date:  1983-11       Impact factor: 5.153

10.  Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay.

Authors:  P Vitti; W A Valente; F S Ambesi-Impiombato; G F Fenzi; A Pinchera; L D Kohn
Journal:  J Endocrinol Invest       Date:  1982 May-Jun       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.